Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection

Rationale: Novel vaccine R&D is essential to interrupt the COVID-19 pandemic and other epidemics in the future. Subunit vaccines have received tremendous attention for their low cost and safety. To improve the immunogenicity of subunit vaccines, we developed a novel vaccine adjuvant system. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ang, Chen, Yunsheng, Liang, Hui, Cui, Xinyuan, Zhang, Amin, Cui, Daxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526668/
https://www.ncbi.nlm.nih.gov/pubmed/37771766
http://dx.doi.org/10.7150/thno.83390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526668/
https://www.ncbi.nlm.nih.gov/pubmed/37771766
http://dx.doi.org/10.7150/thno.83390

Ejemplares similares